Lv1
50 积分 2025-04-22 加入
Efficacy and Safety of Guselkumab Therapy in Patients With Moderately to. Severely Active Crohn's Disease: Results of the GALAXI 2 & 3 Phase 3 Studies
1天前
待确认
Comparative Efficacy of Novel Biologics, Antitumour Necrosis Factor Agents, and Immunomodulators to Prevent Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-analysis
15天前
已关闭
Comparative Efficacy of Novel Biologics, Antitumour Necrosis Factor Agents, and Immunomodulators to Prevent Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-analysis
15天前
已完结
皖公网安备34019202002308
